Home Tags The Motely Fool
Tag: The Motely Fool
11/2/19--Shares of Innovative Industrial Properties (NYSE:IIPR) declined 17.7% in October, according to data from S&P Global Market Intelligence. The stock's return was also negative 17.7%, since no dividends were paid during the month. Innovative Industrial stock's subpar showing in October is being attributed to continued weakness in the overall cannabis sector rather than to company-specific happenings. Read
12/10/18--The newly public Curaleaf Holdings is attempting to show the world that not all marijuana companies will throw their shareholders under the bus during a rapid expansion process. Between Dec. 12, 2018, and Dec. 12, 2019, it plans to commence share repurchases totaling as much as $50 million, albeit the timing and amount of shares to be repurchased will depend on market conditions and other variables. Read
9/27/18--The marijuana industry in Canada has exploded, with many Canadian marijuana stocks skyrocketing as well. What's going on now with marijuana in Canada? What threats exist for the marijuana industry? What are the best ways for investors to profit from the rapidly growing marijuana market? The Motley Fool presents everything you need to know about investing in Canadian marijuana stocks. Read
9/27/18--The Drug Enforcement Agency (DEA) has awarded GW Pharmaceuticals' epilepsy drug, Epidiolex, Schedule V status, its least restrictive classification. The decision clears the way for GW Pharmaceuticals to begin offering the only CBD oil that's cleared by the DEA for use nationwide, and it puts the company on a path to disrupt how doctors treat patients who fail to respond to existing anti-epilepsy medications.
9/11/18--Marijuana stocks offering competitive advantages might prove attractive to investors. Throughout the industry, there are four such niche stocks that bring massive market share potential to the table: CannaRoyalty, Kush Bottles, GW Pharmaceuticals, and Innovative Industrial Properties. Read
8/12/18--Based on the continued expansion of countries and states that allow legal medical marijuana, it may be assumed that global medical marijuana spending will keep on growing in 2018 like it has in previous years. However, Arcview Market Research and BDS Analytics project that global medical marijuana spending will drop by more than 19% year over year in 2018. Yet, medical marijuana sales are expected to increase again, and the growth rate over the next four years should be nearly as impressive as the period between 2014 and 2017. Read